Our Stocks to Watch today include Advanced Visual Systems Inc. (OTC: AVSC), Muscle Flex Inc. (OTC: MFLI), Magnum D'Or Resources Inc. (OTCBB: MDOR), Biomagnetics Diagnostics Corp. (OTC: BMGP), NT Media Corp. (OTCBB: NTMI), MSE Enviro-Tech Corp. (OTC: MEVT), XTend Medical Corp. (OTC: XMDC), Bergamo Acquisition Corp. (OTC: BGMO), Health Discovery Corp. (OTCBB: HDVY), Clear Skies Solar Inc. (OTCBB: CSKH) and Accredited Business Consolidators Corp. (OTC: IOVE).
Visit http://www.otcpicks.com/microcap.htm to register for our Daily Market Mover’s Digest Newsletter and Email Stock Watch Alerts.
ADVANCED VISUAL SYSTEMS INCORPORATED (OTC: AVSC)
Detailed Quote: http://www.otcpicks.com/quotes/AVSC.php
Company Profile: http://www.otcpicks.com/advanced-visual-systems.htm
Advanced Visual Systems Inc. (AVS) provides industry-leading, interactive data visualization software and solutions that help business, scientific and engineering users gain critical insight from all types of data. AVS's complete line of software products speed decision-making by bringing information to life using the latest in graphics, Web-based and interactive technologies on all major computing platforms.
AVSC News:
October 22 - Advanced Visual Systems to Spin Off New Technology for Monitoring
Advanced Visual Systems Inc. (OTC: AVSC), a data visualization software innovator, plans to spin off a new technology for monitoring and managing Enterprise IT and revenue networks. The company is in discussion with several potential partners and plans to debut the spin off before year-end.
The new entity, in which AVS will hold a significant stake, will be known as VizStar and will develop comprehensive solutions for
According to David M. Murray, President of AVS, "Based upon our experience working with several visionary Enterprise accounts, we see an emerging demand for real-time solutions that reveal the hidden stresses and inefficiencies of large corporate IT and revenue networks. Our plan is to create applications that not just identify performance issues — but also provide ways to easily test and implement changes that will directly lead to improved profitability."
Upon formation, VizStar plans to immediately commence development of a solution for use by IT professionals to monitor, manage, and administer the capacities and requirements of sophisticated computer, communication and disaster recovery networks. Anticipated benefits for VizStar customers include increased utilization of IT assets and a significant reduction in energy consumption.
The company also plans to develop a branded solution that will tap into
MUSCLE FLEX INCORPORATED (OTC: MFLI)
Detailed Quote: http://www.otcpicks.com/quotes/MFLI.php
Company Profile: http://www.otcpicks.com/muscle-flex-inc.htm
Muscle Flex Inc. brings new products to market using direct response TV infomercials specializing in the health, fitness, wellness and hygiene sectors. As well, Muscle Flex Inc. develops and creates general television content for network and cable television distribution. Muscle Flex's corporate strategy is to develop new and innovative products for sale and distribution via its proprietary direct response marketing system and the creation of television media and shows for general network and cable broadcast.
MFLI News:
October 22 - Muscle Flex Completes the Filming of The BUDDY Tablet Caddy and The Beagle StepFit Infomercials and Prepares for the November Product Launch
Muscle Flex Inc. (OTC: MFLI) (www.MuscleFlexInc.com) announced that it has completed filming of the BUDDY Table Caddy™ (www.BuddyTabletCaddy.com) and The Beagle StepFit™ (www.BeagleStepFit.com) Pedometer infomercials and is preparing for the November 2009 launch. The filming for the Muscle Flex Beagle was completed on Monday October 19 and was filmed and produced by Showreel International Inc. (www.Showreel.com). The results far exceeded the expectations of Muscle Flex and Showreel as the concepts, filming and the final footage results were sensational.
Details of the Beagle StepFit and the BUDDY Tablet Caddy scripts and commercial concepts are being kept secret until their official viewing for the market and investors which is expected within the next two weeks ahead of the television airing on national cable and network broadcast in November 2009.
"We are extremely excited and fired up at Muscle Flex," commented Danny Alex, CEO and Founder of Muscle Flex Inc. "The filming and the concepts for both the Beagle and the BUDDY were both innovative and cutting edge for the direct response idiom and we are ecstatic at the results. The BUDDY and the Beagle are only the first two of many product releases for Muscle Flex and it is going to be a fantastic way for this company to get started. We have kept the scripts and concepts very secretive until now but, with the final commercial edits expected within days, we are eager to release the final commercial cuts for investors. We will pre-release the commercials along with their respective one-page landing pages within the next couple of weeks ahead of their November national launch dates. We are already planning and developing the next four commercials for Muscle Flex but I fully expect the BUDDY and the Beagle to make Muscle Flex a company that a lot of people will have to acknowledge as a true innovator and leader in the fitness and lifestyle direct response category."
Muscle Flex is preparing for the November national launch of the The BUDDY Tablet Caddy and The Beagle StepFit™ infomercials. Muscle Flex will be launching both products simultaneously with each product being featured in its own 2-minute infomercial.
October 21 - Muscle Flex Completes the Filming of The BUDDY Tablet Caddy and The Beagle StepFit Infomercials and Prepares for the November Product Launch
Muscle Flex Inc. (OTC: MFLI) (www.MuscleFlexInc.com) announced that it has completed filming of the BUDDY Table Caddy™ (www.BuddyTabletCaddy.com) and The Beagle StepFit™ (www.BeagleStepFit.com) Pedometer infomercials and is preparing for the November 2009 launch. The filming for the Muscle Flex Beagle was completed on Monday October 19 and was filmed and produced by Showreel International Inc. (www.Showreel.com). The results far exceeded the expectations of Muscle Flex and Showreel as the concepts, filming and the final footage results were sensational.
Details of the Beagle StepFit and the BUDDY Tablet Caddy scripts and commercial concepts are being kept secret until their official viewing for the market and investors which is expected within the next two weeks ahead of the television airing on national cable and network broadcast in November 2009.
"We are extremely excited and fired up at Muscle Flex," commented Danny Alex, CEO and Founder of Muscle Flex Inc. "The filming and the concepts for both the Beagle and the BUDDY were both innovative and cutting edge for the direct response idiom and we are ecstatic at the results. The BUDDY and the Beagle are only the first two of many product releases for Muscle Flex and it is going to be a fantastic way for this company to get started. We have kept the scripts and concepts very secretive until now but, with the final commercial edits expected within days, we are eager to release the final commercial cuts for investors. We will pre-release the commercials along with their respective one-page landing pages within the next couple of weeks ahead of their November national launch dates. We are already planning and developing the next four commercials for Muscle Flex but I fully expect the BUDDY and the Beagle to make Muscle Flex a company that a lot of people will have to acknowledge as a true innovator and leader in the fitness and lifestyle direct response category."
Muscle Flex is preparing for the November national launch of the The BUDDY Tablet Caddy and The Beagle StepFit™ infomercials. Muscle Flex will be launching both products simultaneously with each product being featured in its own 2-minute infomercial.
MAGNUM D'OR RESOURCES (OTCBB: MDOR)
Detailed Quote: http://www.otcpicks.com/quotes/MDOR.php
Company Profile: http://www.otcpicks.com/magnum-resources/magnum-resources.htm
Magnum d'Or Resources, Inc. focuses in operating in recycling and waste management sectors. It intends to develop facilities that produce rubber powders, thermoplastics, and thermoplastics elastomers. Magnum holds licensing rights to various patents that would allow rubber to be devulcanized, specialty blend EPDM powders, and EPDM compounds. The company was founded in 1999 and is based in
MDOR News:
October 22 - Magnum SRI Custom Compound Tire Equipped Truck Commences Validation Testing at the Malaysian Rubber Research Institute
A Historic Moment and World First in Recycling Technology
Magnum D'Or Resources, Inc. (OTCBB: MDOR), a next generation rubber recycling Solutions Company, announced that the Magnum SRI custom compound light truck tires were installed onto the pre-specified truck and driven to the Rubber Research Institute of the Malaysian Rubber Board's Tire Lab (RRI) where the "On Road" validation and testing of the tires will be carried out as per their protocol. No standard protocol currently exists to specifically deal with Magnum SRI Tires. At 14% recycled content, this is nearly 6 fold what exists today in terms of surface treated crumb in tires, whether truck or automotive. The performance specifications achieved thus far by the Magnum SRI custom compound tires clearly equal the original control specimen and is being treated as an OEM tire and tested with the same procedure(s).
We were honoured by the interest shown by the Director of the Research Facility Dr. Alias Othman and the Head of the Advance Technology Unit. Both individuals were present to witness the historic event where substantial recycled content was incorporated into a premium production tire for the very first time without any loss in properties while affording a reduction in raw material cost in-between 6% to 8% to the manufacturer.
Visit http://magnumresources.net/gallery/?level=album&id=6 to view pictures taken at the RRI.
The two Magnum SRI Tires and two control tires were thoroughly marked and measured prior to the truck being driven off on its maiden 800km round trip journey. The trip will include travel north to collect the latest production of Magnum SRI custom tires for further testing. The truck is equipped with a black box packed with monitoring hardware and tracking systems to check all aspects of the vehicles operating conditions to be included as part of the evaluation. This will prove to be the crown jewel of the Magnum SRI venture by documenting the results showing that the performance exceeds all expectations, and byre-writing the rules about what can and cannot be done in the recycling industry.
Particularly noteworthy is the fact that the Magnum SRI Compound Test Tire is a composite compound using the OEM manufacturers Light Truck compound formula with a substitution of 20% of Magnum SRI custom Compound (14% recycled rubber content). In this case it means that tread compound has 14% of recycled content and the sidewall of the tire has a little more than 14% recycled content. Virgin compound modified to allow for customization added to the activated compound will make the final custom compound proportion 20%. There is truly significant in that the Magnum SRI activated compound was not only incorporated into the tread compound but it was also introduced into the sidewall compound of these 'Next Generation' Magnum SRI Truck Tires
Magnum SRI — The Complete Rubber Recycling Solution
Magnum's proprietary "GREEN" technology provides a one-of-a-kind solution to all of the challenges in eliminating stockpiles of scrap tires and rubber scrap. Magnum has positioned itself to become a global leader in rubber and scrap tire recycling and its proprietary technology and know-how could potentially revolutionize the industry Worldwide.
Magnum Recycling
Magnum's Recycling USA: Magnum's
Magnum Engineering International ('MEI') (http://magnumei.com) is a wholly owned subsidiary of Magnum specializing in developing turnkey recycling plants and complete environmental & economical 'Green' solutions.
Magnum/SRI are currently using their Revolutionary technologies to produce next generation rubber recycling solutions for custom compounds, retread compounds, processing aids, advanced state-of-the-art equipment, and reactivated ambient/cryogenic rubber powders for the global market. Magnum/SRI premium compounds can be substituted in high specification compound applications without appreciable loss in properties or performance. The reason why our clients (market) will prefer to use Magnum/SRI compounds is because they will be able to enjoy a substantial and meaningful reduction in raw material cost without compromising product performance and quality. In the competitive environment of rubber product manufacturing this is a major development having a direct positive impact on our customer's bottom line.
BIOMAGNETICS DIAGNOSTICS CORPORATION (OTC: BMGP)
"Up 22.55% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/BMGP.php
Company Profile: http://www.otcpicks.com/biomagnetics-diagnostics/biomagnetics-diagnostics.htm
Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. The Company's revolutionary diagnostic systems, which are based on advanced magnetics, test for any viral or bacterial disease using any body fluid. The Company's technology allows laboratories to perform far more tests in the same amount of time it takes to do a single test. The HTS-MTP platform is designed to detect the actual virus and viral load in body fluids and not just simply screen for the presence of viral antibodies.
BMGP News:
October 19 - Biomagnetics Diagnostics Completes Equity Financing Round; Prepares Entry into Malaria and Tuberculosis Diagnostics Markets
Biomagnetics Diagnostics Corp. (OTC: BMGP), a producer of revolutionary diagnostic systems and technology for malaria, tuberculosis, HIV and hepatitis testing today announced the completion of its equity financing designed to fund entry into the Integrated Optical Biosensor Systems (IOBS) market. Through this round of equity financing the Company received cash and commitments of approximately $1 million from several private investors and a single philanthropic organization.
“We view the market for both malaria and bovine tuberculosis testing to be significantly underserved with few viable field deployable technologies available. In 2010 we plan to introduce a new generation of products to target this area. This equity financing will be instrumental in this market entry,” commented Clayton Hardman, CEO of Biomagnetics Diagnostics. “We believe this technology upon commercialization will not only be profitable for Biomagnetics and our investors, but will also provide an important tool in the medical, research and anti-bioterrorism communities that can potentially improve and save lives.”
According to the World Health Organization, some 3.2 billion people, or about half the world's population is at risk of malaria transmission in 107 countries and territories worldwide. While there are between 350 million and 500 million new cases of malaria each year, there are very few reliable and field deployable diagnostic tools available. In the case of malaria, early detection substantially improves treatability and survivability. TB (tuberculosis) is the second leading cause of death from infectious disease worldwide. Bovine TB is a growing problem through out the world with an estimated 1.3 billion cattle at risk. In the United States, where the cattle industry is valued at $60 billion annually, the use of existing diagnostic tests currently add $5.00 to $15.00 on average per head to the cattle industry's costs. Field deployable integrated optical biosensor systems hold the promise to significantly speed the diagnostic testing process and to meaningfully lower costs.
NT MEDIA CORPORATION (OTCBB: NTMI)
Detailed Quote: http://www.otcpicks.com/quotes/NTMI.php
Company Profile: http://www.otcpicks.com/nt-media.htm
NT Media is a start-up digital media solutions provider and developer of niche content websites. The interactive and community-oriented content for NT Media sites, as well the sites' advertising, target specific interest groups and demographics in order to create an ongoing and open dialogue on trending topics and issues. NT Media's online communities integrate increasing trends in online social networking and community building, user generated original content and third-party applications.
NTMI News:
October 15 - NT Media to Produce Original Series for NeuroTrash.tv
Video-Sharing Site NeuroTrash.tv Launches Ongoing Original Content Initiative With a New Comedy Webisode
NT Media Corp. (OTCBB: NTMI), a developer and operator of media and social networking websites, announced that it will produce an original comedy series exclusively available on its alternative-format video-sharing site NeuroTrash.tv as part of an ongoing program to publish and distribute original content.
The video, currently in pre-production, will feature anecdotal nightlife experiences with the comedic performances of an ensemble cast. Production is scheduled to begin in November and the webisode is scheduled to be released at the first part of 2010.
Launched in January 2009, NeuroTrash.tv is a video-sharing site targeting young adults between the ages of 18 and 35. Users are able to post and share videos on the site, and take advantage of the site's video player for sharing original videos on their own sites, social networking profile pages and blogs.
"The production of NeuroTrash.tv's first original video is a milestone for both the community and NT Media," said NT Media CEO Ali Moussavi. "The webisode will appeal to our target audience, and we anticipate its viral release will draw increased attention to the value of NeuroTrash.tv and will position the site as a leader of a highly-demanded niche."
NT Media's revenue model for NeuroTrash.tv is based on standard display banner ads, in-stream video advertising, products sales and services. Advertisers are also able to earn revenue from video ads embedded in other websites on which NeuroTrash.tv users place videos. For advertising and sponsorship opportunities please email contact@ntmedia.tv.
MSE ENVIRO-TECH CORPORATION (OTC: MEVT)
"Up 94.00% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/MEVT.php
MEVT owns the
MEVT News:
October 9 - MSE Enviro-Tech Corp. Awarded Exclusive Rights to Distribute Specialty Concrete Coating Products Throughout the
MSE Enviro-Tech Corp. (OTC: MEVT) (Frankfurt: MEH) announced that it has acquired from IMCO Technologies Inc. the exclusive rights to distribute IMCO's patented products designed to protect and enhance the performance of concrete structures, which covers the vast majority of residential and commercial buildings in the Caribbean. In keeping with the Company's goal of expanding its product offerings in light of rising demand for environmentally friendly, technology based products, this exclusive distributorship compliments MEVT's primary business and offers additional potential for growth and enhancement of corporate value.
Throughout the
"Successful acquisition of the rights to distribute the IMCO® products expands MEVT's marketing and growth potential through the addition of another important dimension to the Company's line of building protection products. We are increasingly optimistic regarding the outlook for the Company's marketing plans given this exciting new addition," said Mr. Gilles Trahan, CEO-President of MSE Enviro-Tech Corp.
ABOUT IMCO TECHNOLOGIES INC.
Since 1982, IMCO® products have solved concrete and steel maintenance problems worldwide. With a background as engineers and industrial contractors, and equipped with unique chemical technologies, the company set out to develop protective coating systems and concrete repair materials and has exceeded those goals. Each product has been developed to meet a particular challenge within the construction, plant maintenance and building restoration businesses. Over the years, IMCO® products have earned a rising profile in construction and engineering companies across
XTEND MEDICAL CORPORATION (OTC: XMDC)
"Up 57.69% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/XMDC.php
XTend Medical is a company that specializes in the manufacturing and distribution of the latest in telemedicine and telehealth solutions for the healthcare industry. Their dedication to insuring the products and services offered to healthcare organizations, third-world countries, and physician groups are at the forefront of medical technology. Their continued efforts in identifying global companies with true product potential in the healthcare industry puts them in an advantageous position to capitalize on a global basis.
XMDC News:
October 22 - XTend Medical Updates Shareholders on Merger and Company's Progress
Management to Travel to
XTend Medical Corp. (OTC: XMDC), a company specializing in manufacturing and distributing the latest in telemedicine and diagnostic devices, released the following information regarding the company's progress on merger and company's progress:
"XTend would like to update our shareholders on our progress to date. Mr. Lee from
The combined efforts of the seasoned technical team in
As to the BioHarp unit itself, I would like to reiterate a few areas that make this device unique:
1. The BioHarp requires a pre-scan of the patient in order to get a baseline reading. This baseline reading is not based solely on a set of standards in the medical sector. These individualized baselines are established from the patient's own cellular makeup and further solidify how the BioHarp sets itself apart from any present of future competitors.
2. The BioHarp device is completely portable. Unlike CT Scanners and other large pieces of equipment that remain stationary, the BioHarp can travel to where the patients are. The unit is perfect for rural areas, battlefields, or other outlying areas that would benefit by having the BioHarp as part of their healthcare service.
3. BioHarp can be used to detect cellular inflammation in plants. Diseases in crops have risen dramatically over the years and the BioHarp can assist scientists in helping to determine the proper course of treatment in order to insure plants can sustain life. The global percussion in this area can be tremendous for the company.
4. The dedication Mr. Lee has spent on this device over the past 14 years is truly incredible. His vision for this device has proven instrumental in the development of the BioHarp. His technical staff has, and continues t, spend countless hours perfecting this product and we feel honored to become part of this exciting and truly unique product.
In closing, I would like to thank all of our shareholders for being patient as we close this merger. Mr. Lee and I have worked continuously over the past two years to insure you, as shareholders, will reap the benefits of being part of something we're very proud of. The future is very bright for this company and through hard work and dedication, the BioHarp will flourish and become the leading diagnostic device in the global medical community," stated Mr. Paul D. Lisenby, CEO of XTend Medical.
BERGAMO ACQUISITION CORPORATION (OTC: BGMO)
"Up 7.94% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/BGMO.php
Bergamo Acquisition Corp., through its wholly owned subsidiary, Bergamo E&A Corp., focuses on the development of clean energy infrastructure projects in
BGMO News:
October 21 - Bergamo Acquisition Corp. Updates Investors on Domestic Acquisitions
Senior Management in
Bergamo Acquisition Corp. (OTC: BGMO) announced that CEO Hillard Herzog is in
CEO Hillard Herzog commented, "I am very excited about the acquisitions for which we are negotiating. We understand the investor interest in all of the projects. I know shareholders will be pleased by what we arrange in the coming days. Ultimately, we are not going to be able to update investors further until everything is finalized and all contracts are executed. That's when the real work begins."
HEALTH DISCOVERY CORPORATION (OTCBB: HDVY)
"Up 6.45% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/HDVY.php
Savannah-based Health Discovery Corporation is uniquely positioned in the field of pattern recognition technology. Through the application of its patent protected technology, HDC is a leader in SVM-based molecular diagnostic and prognostic test development in genomics and proteomics, as well as, digital image analysis in pathology and radiology. The Company's SVM and FGM pattern recognition tools have significant application potential in other sizable commercial markets such as oil exploration, financial markets, Internet search and spam, homeland security, and other areas where analysis of large volumes of complex data is required.
HDVY News:
October 19 - Health Discovery Corporation Announces Additional Issued Patents and Notices of Allowance to Its Intellectual Property Portfolio
Health Discovery Corporation (OTCBB: HDVY) announced numerous additional issued patents and Notices of Allowance since its last press release describing its intellectual property portfolio. The Company now has a total of 37 issued patents, 4 Notices of Allowance and 30 pending patent applications.
New
The United States Patent and Trademark Office (USPTO) issued a patent to HDC that includes additional, broader claims to the Company’s exclusive Recursive Feature Elimination (RFE) using Support Vector Machines (“SVM”) or SVM-RFE method, the first patent for which issued in 2006. The SVM-RFE method has been used to successfully identify the most important pieces of information needed to solve complex pattern-recognition problems and has been shown in numerous peer-reviewed publications from some of the worlds top academic institutions to be a superior technology for the successful discovery of new molecular diagnostic/prognostic tests for personalized medicine. HDC has the only issued patents in the world for the SVM-RFE technology, which was discovered by members of the HDC science team. The SVM-RFE technology was the method used to discover the Company’s new tissue and urine based prostate cancer tests recently licensed to Quest Diagnostics (NYSE: DGX), Abbott Laboratories (NYSE: ABT) and Clarient Inc. (Nasdaq: CLRT).
The European Patent Office issued a notice of its intent to grant a patent covering HDC’s SVM-based computer-aided image analysis techniques. Corresponding patents have already been granted in the
Another newly issued USPTO patent covers an SVM-based data-mining platform for classification of data from heterogeneous biological datasets.
The USPTO also issued a new patent to HDC covering a data-mining platform with multiple SVM modules for use in analyzing bioinformatics data.
In addition, the USPTO issued a new patent to HDC, which covers the use of SVM technology for ranking of input features for selection of the most relevant input parameters needed to classify data.
HDC was also issued a patent in
An Indian patent was issued to HDC covering the use of SVMs for knowledge discovery from multiple data sets. This patent further expands HDC’s patents for integrating patient data from multiple sources such as genomic data, clinical data, digital pathology data and radiologic data. This integration of data is thought to be the “Holy Grail” of personalized medicine.
A New FDA-Approved Ovarian Cancer Test based on an HDC Patented Technology
HDC’s patented technology played a pivotal role in identifying biomarkers in a recently FDA-approved ovarian cancer test developed by Vermillion, Inc. (OTC: VRMLQ).
HDC prosecuted a patent infringement action against Vermillion’s predecessor company, Ciphergen Biosystems, Inc., which resulted in a $600,000 cash settlement in favor of HDC and a grant of a limited license to Vermillion by HDC. The HDC limited license grant to Vermillion is for non-exclusive use solely for Vermillion’s SELDI-based mass spectrometer technology.
HDC’s License Partners
HDC’s key license partners to date include Abbott Laboratories (NYSE: ABT), Quest Diagnostics (NYSE: DGX), Clarient Inc. (Nasdaq: CLRT) and Pfizer Inc. (NYSE: PFE).
HDC recently entered into royalty-bearing licenses for its new urine-based prostate cancer test with Quest Diagnostics Incorporated and Abbott Laboratories for development and commercialization. These licenses are solely for the use of HDC’s prostate cancer biomarkers in urine.
HDC also entered into royalty-bearing licenses for its tissue biopsy-based prostate cancer test with Abbott Laboratories and Clarient Inc. for development and commercialization. This license is solely for the use of HDC’s prostate cancer biomarkers in tissue biopsy specimens.
HDC has also partnered with Pfizer Inc. for use of HDC’s SVM and SVM-RFE pattern recognition technology in Pfizer’s global research and development.
HDC has also entered into a license with Smart Personalized Medicine, LLC (“SPM”), a privately-held company, founded by Dr. Richard Caruso, Chairman and founder of Integra Life Sciences (Nasdaq: IART) to develop a superior breast cancer prognostic test using HDC’s SVM technology in cooperation with MD Anderson Cancer Center. HDC has a fifteen percent equity position in SPM and HDC will receive royalties from this new breast cancer prognostic test.
HDC has entered into a development and license agreement with DCL Medical Laboratories, LLC, for the collaborative development and commercialization of SVM-based computer assisted diagnostic tests for the independent detection of ovarian, cervical and endometrial cancers.
HDC’s Patents Cover Non-Medical Applications
There are a large number of non-medical applications protected by HDC’s patents, including but not limited to, fraud detection, investment and commodities price predictions, bankruptcy prediction, image and object analysis, face recognition, text and document classification, speech recognition, personalized consumer purchasing patterns, decryption, vehicle control and monitoring, weather forecasting and database marketing.
Total Number of Patents Pending and Issued
With the issuance of the new patents described above, HDC now holds exclusive rights to a total of 37 issued
HDC’s Successful Prosecution of Patent Infringement Cases
In addition to the Vermillion patent infringement case described above, HDC successfully prosecuted a patent infringement lawsuit against Equbits LLC, which resulted in a permanent injunction against Equbits, LLC.
“HDC is determined to continue to grow and protect its valuable intellectual property portfolio. The Equbits judgment and Vermillion settlement and limited license strengthens our licensing posture in the marketplace and sets the appropriate tone for our future enforcement efforts,” stated Stephen D. Barnhill, M.D., HDC’s Chairman and CEO.
“HDC remains firmly committed to successfully monetizing our valuable intellectual property through additional licensing, close collaboration, development and commercialization with our business partners and we will also continue to protect our patent portfolio through robust enforcement action when strategically appropriate," said Dr. Barnhill.
HDC’s patent strategy includes a significant after-claiming component with multiple CIP’s and Continuations already in place.
CLEAR SKIES SOLAR INCORPORATED (OTCBB: CSKH)
"Up 4.17% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/CSKH.php
Clear Skies Solar, Inc. designs, markets, sells, and installs solar power systems and renewable energy technology solutions for commercial and residential customers in the
CSKH News:
October 20 - Clear Skies Solar Receives $700,000 in Equity Funding
European Investment Group Led by Major German Solar Company Injects Cash
Clear Skies Solar, Inc. (OTCBB: CSKH) announced the sale of $700,000 of common stock, which together with prior debt and equity financings aggregates $1.6 million raised in the past 5 months. The Company believes this latest investment will help fuel the growth curve anticipated by Clear Skies Solar (CSS). The group of investors was led by a large publicly traded European solar energy firm that has recognized the abilities and opportunities available to CSS.
"This cash investment is further evidence that the markets are opening up and investors are recognizing the competitive abilities of CSS. We have taken the company post market collapse and returned it to a healthier entity with a more aggressive business plan than originally designed. We have previously told our shareholders that we had the ability and the opportunities to grow and I am pleased to say we are beginning to deliver on that promise and believe that the best is yet to come," says Ezra Green, CEO of CSS.
Green continues, "With multiple contract opportunities being discussed, we hope to start growing rapidly in the near term. As we enter this new era of expected growth, we have structured the company to operate at a higher level of competitiveness. Since we believe our cost of execution is lower than many other companies our closing rate will be increasing while maintaining project profitability and quality."
ACCREDITED BUSINESS CONSOLIDATORS CORP. (OTC: IOVE)
"Up 6.92% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/IOVE.php
Accredited Business Consolidators Corp., formerly known as the Italian Oven, is a diversified holding corporation. Visit www.accreditedbiz.com (under construction) for information on its affiliated companies. The total number of common shares outstanding is 436,399,500. 328,018,200 shares are in the public float and on hand with CEDE & Co., 70,546,600 shares are restricted in certificate form, and 37,834,700 shares are unrestricted but in certificate form. There will be no increase in shares until at least April 2010.
IOVE News:
October 22 - Accredited Business Consolidators Corp. Submits Application to FINRA for New Symbol
Accredited Business Consolidators Corp., trading as Italian Oven, Inc. (OTC: IOVE), submitted an application to the Financial Industry Regulatory Authority (FINRA) for a new symbol to reflect its new name. The time period necessary for FINRA to issue a new symbol depends on their schedule and the number of other applications that are pending.
In response to shareholder inquiries, the Company advises that it continues to work on the necessary documents regarding the share dividends of Richwood Eco Ventures, Inc. and Accredited Consolidators Europe PLC. The dividend documentation is expected to be submitted to FINRA within ten business days after the change of name. The shares will not have restrictions on them and will be free trading; however, they will not be able to be traded on the open market until a regulatory filing is submitted to the appropriate agencies and a market maker, or in the case of ACE PLC, a NomAd (Nominated Adviser), agrees to sponsor the Company.
The Company clarifies that shareholders maintaining their shares with a broker do not need to take any action. The broker will process both the name change and the share issuances. In the case of investors with certificates, it is not necessary to turn in your shares. This can be done in the future when you deposit or transfer your shares. As to the dividends, shareholders with certificates should pay careful attention to future press releases and regulatory filings for instructions.
OTCPicks.com is located at
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.
Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.
Information contained in our report will contain "forward looking statements" as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company's most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company's operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov/ and FINRA at http://www.finra.org/.
Disclosure: OTCPicks.com has been compensated seven thousand five hundred dollars from BlueWave Advisors for AVSC advertising and promotional services. OTCPicks.com has been compensated three thousand five hundred dollars from Dana Alex for MFLI advertising and promotional services. OTCPicks has been compensated ten thousand dollars from a non-controlling third party (GREEN TECH INTERNATIONAL ADVISORS) for MDOR advertising and promotional services. OTCPicks is being compensated one hundred thousand free trading shares by a third party for NTMI advertising and promotional services. OTCPicks.com has been compensated seven thousand five hundred dollars by a third party for BMGP advertising and promotional services. OTCPicks.com has been compensated ten thousand dollars by the company for a current BMGP advertising and promotional services. OTCPicks.com have been compensated eight thousand dollars by a third Party (Geneva Bancorp) for MEVT advertising and promotional services. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. OTCPicks.com is a website partially owned by BlueWave Advisors, LLC, a financial public relations firm. BlueWave Advisors, LLC, its principal and/or its affiliates will hold positions in the company profiled and may buy or sell securities at any time without notice.
